ArticleTranslational cancer research2026
Comparison of 5-year survival rates and prognostic factors between adenoid cystic carcinoma and squamous cell carcinoma of the maxillary sinus: a SEER database analysis.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Maxillary sinus carcinoma is a rare and heterogeneous sinonasal malignancy, with prognosis varying substantially by histological subtype. Maxillary sinus adenoid cystic carcinoma (MSACC) and maxillary sinus squamous cell carcinoma (MSSCC) differ in biological behavior and clinical outcomes, but direct comparisons between them remain limited. This study used the Surveillance, Epidemiology, and End Results (SEER) database to compare the 5-year survival differences between MSACC and MSSCC, and to explore the prognostic factors of these two tumors. Methods: Patients with MSACC and MSSCC diagnosed between 2004 and 2019 were identified from the SEER database. Overall survival (OS) and cancer-specific survival (CSS) were set as primary outcomes. Kaplan-Meier curves and log-rank tests were used for survival comparison. Cox proportional hazards regression was applied to determine independent prognostic factors. A prognostic model was constructed based on these factors. Results: Kaplan-Meier analysis showed significantly better survival in MSACC compared with MSSCC (log-rank P<0.001). The 3- and 5-year OS rates were 73.2% and 58.5% for MSACC versus 39.6% and 32.7% for MSSCC, while the 3- and 5-year CSS rates were 78.0% and 64.6% versus 51.2% and 46.3%, respectively. Multivariate Cox regression identified age >60 years, advanced T stage, and absence of surgery as independent adverse prognostic factors, while radiotherapy was associated with improved survival. The prognostic model incorporating these factors demonstrated good discrimination and calibration. Conclusions: Patients with MSACC have significantly better OS and CSS than those with MSSCC. Age, T stage, surgery, and radiotherapy are important prognostic factors. The prediction model based on these variables may serve as a useful tool for prognostic evaluation and risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.